Michelle V. Stacy Joins Flex Pharma’s Board Of Directors

BOSTON--(BUSINESS WIRE)--Click to Tweet

th the consumer and drug development arms of the business” Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing innovative and proprietary treatments for nocturnal leg cramps (NLC), spasms associated with severe neuromuscular conditions, and exercise-associated muscle cramps, announced today that Michelle V. Stacy, former President of Keurig Inc., has joined its Board of Directors.

MORE ON THIS TOPIC